Cargando…
P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642054/ http://dx.doi.org/10.1097/01.HS9.0000891012.42031.20 |
| _version_ | 1784826220996722688 |
|---|---|
| author | Kambhampati, Swetha Mei, Matthew Chen, Lu Puvurel, Sandrine Chen, Robert Popplewell, Leslie Nikolaenko, Liana Peters, Lacolle Armenian, Saro Kwak, Larry Rosen, Steven T. Forman, Stephen Herrera, Alex F. |
| author_facet | Kambhampati, Swetha Mei, Matthew Chen, Lu Puvurel, Sandrine Chen, Robert Popplewell, Leslie Nikolaenko, Liana Peters, Lacolle Armenian, Saro Kwak, Larry Rosen, Steven T. Forman, Stephen Herrera, Alex F. |
| author_sort | Kambhampati, Swetha |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9642054 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96420542022-11-14 P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma Kambhampati, Swetha Mei, Matthew Chen, Lu Puvurel, Sandrine Chen, Robert Popplewell, Leslie Nikolaenko, Liana Peters, Lacolle Armenian, Saro Kwak, Larry Rosen, Steven T. Forman, Stephen Herrera, Alex F. Hemasphere Relapsed/Refractory Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9642054/ http://dx.doi.org/10.1097/01.HS9.0000891012.42031.20 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Relapsed/Refractory Kambhampati, Swetha Mei, Matthew Chen, Lu Puvurel, Sandrine Chen, Robert Popplewell, Leslie Nikolaenko, Liana Peters, Lacolle Armenian, Saro Kwak, Larry Rosen, Steven T. Forman, Stephen Herrera, Alex F. P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma |
| title | P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma |
| title_full | P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma |
| title_fullStr | P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma |
| title_full_unstemmed | P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma |
| title_short | P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma |
| title_sort | p111: phase i trial of brentuximab vedotin plus cyclosporine in relapsed/refractory hodgkin lymphoma |
| topic | Relapsed/Refractory |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642054/ http://dx.doi.org/10.1097/01.HS9.0000891012.42031.20 |
| work_keys_str_mv | AT kambhampatiswetha p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT meimatthew p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT chenlu p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT puvurelsandrine p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT chenrobert p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT popplewellleslie p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT nikolaenkoliana p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT peterslacolle p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT armeniansaro p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT kwaklarry p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT rosenstevent p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT formanstephen p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma AT herreraalexf p111phaseitrialofbrentuximabvedotinpluscyclosporineinrelapsedrefractoryhodgkinlymphoma |